Fuda Cancer Hospital is famous for advance robotics & minimally invasive treatments. Cancer treatment varies from patient to patient.
It is located in Guangzhou (China) & have a consulting clinic and information centre in Mumbai (India). Fuda is committed to providing cancer patients around the world with the best medical care. Fuda Cancer Hospital is considered one of the BEST cancer hospitals in China by patients and is affiliated to Jinan University and Translational Medicine Center of Guangzhou Institute of Biomedicine and Health of Chinese Academy of Sciences. As a tertiary hospital, Fuda operates with international standards and was selected as the National Key Clinical Specialty (Oncology) in 2010. In 2014, Fuda was accredited by the Joint Commission International (JCI), a golden standard of medical service worldwide. Fuda is equipped with 400 beds, 45 VIP rooms and 500 medical staffs to help our patients. Multiple Disciplinary Teams work in Fuda to personalize treatment for every single patient. Those teams include NanoKnife Ablation team (Irreversible Electroporation), Cryosurgical ablation team, cancer micro-vascular intervention team, combined immunotherapy team, and surgical team. Our clinical achievement and academic research are widely accepted by peer doctors and scientific journals. In Fuda, Doctors use more than 20 types of cancer treatment, including those mentioned above, to help our patient LIVE WITH CANCER as long as possible with a quality life. Fuda highly focuses on research and application of advanced clinical procedures and pays tremendous attention on patient care. In the past two decades, Fuda has been active in promoting Minimally Invasive Treatments such as Cryosurgery, NanoKnife, micro-vascular intervention treatment and Brachytherapy. Fuda was the first in China to introduce NanoKnife for clinical use and has accumulated substantial clinical experience. Patients are not just receiving treatment in Fuda, they live a life in Fuda with their family. To date, patients from over 110 countries were treated in Fuda and 50% of them are from South-East Asia, the Middle East, Oceania, Europe and North America. The number of patients treated in Fuda with Minimally Invasive treatments outnumbers any other hospital in the world. Fuda has received various awards in China and abroad for outstanding achievements in treating cancers and has been highly praised by patients worldwide.
24/02/2026
Lung cancer can develop quietly, often without noticeable symptoms in its early stages. Understanding the risk factors is essential for prevention and timely action.
Smoking and to***co use remain the leading causes, while regular exposure to secondhand smoke, air pollution, and harmful occupational substances like asbestos and industrial dust can also significantly increase risk.
Awareness can save lives. Early detection greatly improves treatment outcomes and offers a better chance at recovery. If you experience persistent cough, chest discomfort, or breathing difficulties, seeking medical advice early can make all the difference.
Fuda Cancer Centre, Mumbai – Dedicated to advanced diagnosis, expert-led treatment, and compassionate cancer care. 💙
📞 Contact for appointment: +91 8850860970
Address:- Rustomjee Central Park, Office Spaces, A-302, Andheri - Kurla Rd, opp. Kanakia WallStreet, Chakala, Andheri East, Mumbai, Maharashtra 400069
18/02/2026
Happy Chinese New Year 2026! 🧧🐎
Welcoming the Year of the Fire Horse — a symbol of strength, resilience, energy, and new beginnings.
May this vibrant year bring hope, healing, prosperity, and good health to all. ✨
Warm wishes from everyone at Fuda Cancer Hospital Mumbai ❤️
Together, let’s stride forward with courage and optimism. 🌟
Simple Sore Throat Turned Out to Be Oropharyngeal Cancer:Foreign Patient Refuses Surgery and Travels Across Borders in Search of a “China Solution”
What began as a mild discomfort in the throat gradually worsened—until Robert (pseudonym) could no longer open his mouth properly, speak clearly, or even brush his teeth. Drinking water became difficult. His hearing deteriorated, headaches became frequent, and even the shape of his face slowly changed.
All of this started from what seemed like an “insignificant” throat discomfort.
Robert was born in Antigua and Barbuda, a small island nation in the Caribbean. Toward the end of 2024, he began to feel discomfort on the right side of his throat. At first, he paid little attention. However, the symptoms continued to worsen. By March 2025, he noticed a mass in his oropharynx, yet still delayed seeking medical care.
Two months later, lumps appeared on both sides of his neck, and hearing loss in his right ear became obvious. Only then did he realize the seriousness of the situation and underwent examinations at a hospital in the Philippines.
The diagnosis was devastating: oropharyngeal squamous cell carcinoma. By October 2025, the disease had already progressed.
At that time, Robert was suffering from nasal obstruction on the right side, hearing impairment, difficulty swallowing, swelling and pain in his cheek and throat, and occasional bleeding from the oropharyngeal mass. Everyday life had become a constant ordeal.
Health Insight
The oropharynx, hidden behind the oral cavity, acts as a vital crossroads for breathing, swallowing, and speech. When cancer develops in this area, early symptoms are often subtle and easily overlooked—such as persistent sore throat, a sensation of a foreign body when swallowing, or changes in voice.
Image source: Internet
Seek medical attention promptly if you experience:
• Persistent foreign-body sensation in the oropharynx, especially worsening during swallowing (unlike pharyngitis, which may improve while eating);
• Continuous throat pain affecting daily life;
• Oral ulcers that do not heal, or unexplained bleeding in the mouth;
• Painless neck lumps (enlarged lymph nodes) unresponsive to anti-inflammatory treatment;
• Difficulty opening the mouth or breathing (late-stage symptoms).
If any of these symptoms persist, timely medical evaluation is strongly recommended.
Local doctors advised radical surgery, but the potential extensive trauma led Robert to refuse it. In his mind, surgery was a last resort.
“There must be a more advanced and gentler option,” he believed.
Through social media, Robert learned about Guangzhou Fuda Cancer Hospital in China and its specialized minimally invasive treatment approaches. With a hopeful mindset, he contacted Fuda’s service center in the Philippines and completed an online consultation. When he learned that multiple treatment options were still available to him, he made a decisive choice—to travel to China.
At Fuda, comprehensive examinations revealed that the tumor had invaded the nasopharynx, soft palate, and right-sided muscles, with a high risk of bleeding. Instead of traditional open surgery, the medical team designed a personalized combination treatment plan:
• Arterial infusion chemotherapy to deliver drugs directly to the tumor with high precision;
• Interventional embolization to block blood vessels and reduce bleeding risk;
• Combined with intravenous PD-1 inhibitor immunotherapy, reactivating the immune system to recognize and attack cancer cells.
The results exceeded Robert’s expectations.
Before long, his right nasal passage became clear, his hearing improved, and the neck masses visibly shrank. Swallowing was no longer difficult, and he could finally eat and sleep comfortably again. Although his voice remained slightly hoarse, his laughter was loud and genuine.
CT comparison after two treatment cycles showing reduction of oropharyngeal tumor and cervical masses
Robert shared that he had visited China more than a decade ago, but this was his first time coming to Guangzhou as a patient. At the beginning, anxiety kept his blood pressure elevated. Yet the hospital’s professional expertise and warm, attentive care quickly put him at ease.
This experience made him truly fall in love with China. He said that he hopes to seriously learn Chinese in the future, explore the country’s culture, and fully experience its unique charm.
Robert’s treatment is still ongoing. We sincerely wish him steady progress toward recovery—and a return to a life filled with sound, freedom, and color.
From February 4 to 8, 2026, the Annual Meeting of the Society of Interventional Oncology (SIO) was grandly held in Savannah, USA. Formerly known as the World Conference on Interventional Oncology (WCIO), SIO has been dedicated since its establishment in January 2017 to building, nurturing, and advancing the cutting-edge field of interventional oncology, and has become one of the most influential international platforms for academic exchange in this discipline.
This year’s meeting brought together leading experts, scholars, and clinicians from around the world in interventional oncology and related fields. Through cutting-edge keynote sessions, panel discussions, invited oral presentations, and selected abstract presentations, participants explored multidisciplinary topics spanning radiology, medical oncology, surgery, interventional therapy, hepatology, and radiation oncology, with a shared focus on optimizing existing treatment paradigms and integrating emerging technologies.
Notably, in the Scientific Oral Presentation session, there was only one presentation delivered by a Chinese hospital. This presentation was given by Director Liu Shupeng, a medical expert from Guangzhou Fuda Cancer Hospital, and focused on comprehensive treatment strategies for advanced lung cancer. It highlighted China’s clinical practice and research progress in interventional oncology, contributing Chinese insight and experience to the global development of the field.
The presentation addressed a key challenge in current lung cancer treatment: despite the widespread use of targeted therapies and chemotherapy, some patients still develop drug resistance in the mid-to-late stages of treatment. Director Liu systematically introduced a combined regimen of cryoablation + PD-1 inhibitors + chemotherapy. In this approach, cryoablation induces immunogenic cell death, PD-1 inhibitors restore T-cell function, and chemotherapy enhances tumor antigen exposure. Through their synergistic effects, this integrated strategy offers new therapeutic possibilities for patients with advanced non-small cell lung cancer. This innovative and practice-oriented Chinese approach attracted widespread attention and lively discussion among international peers at the conference.
Taking this opportunity, Guangzhou Fuda Cancer Hospital will continue to deepen its exchanges and collaborations with the international medical community, actively contributing China’s clinical expertise and research perspectives. To date, the hospital has provided medical services to patients from more than 120 countries and regions worldwide. Looking ahead, it will continue to promote the global development of interventional oncology, bringing new hope to more cancer patients around the world.
You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in
10/02/2026
Why Does Oral Cancer Occur?
Oral cancer can develop due to multiple risk factors that often go unnoticed.
To***co use, smoking, and bidi contain harmful chemicals that damage mouth cells.
Excessive alcohol intake weakens oral tissues, increasing cancer risk.
Poor oral hygiene and long-term mouth infections can lead to abnormal cell changes.
HPV infection is also an important cause of oral cancer.
Prolonged sun exposure can increase the risk of lip cancer.
👉 Early detection saves lives.
Regular oral check-ups and timely consultation can make treatment more effective.
📞 Contact for appointment: +91 8850860970
Address:- Rustomjee Central Park, Office Spaces, A-302, Andheri - Kurla Rd, opp. Kanakia WallStreet, Chakala, Andheri East, Mumbai, Maharashtra 400069
Website:- https://fudahospital.in/
You can contact us through the following channels:
☎️ TEL: +91 8850860970
🌟 WhatsApp: +91 8850860970
🌍 Website: https://fudahospital.in/
03/02/2026
【Minimally Invasive Treatment】【Lung nodule-Cryoablation + Simultaneous biopsy】>>>Companion Puncture Technique: A Breakthrough in Biopsy of Small Lung Nodules https://en.fudahospital.com/ You can contact us through the following channels:☎️ TEL: +91 8850860970 🌟 WhatsApp: +91 8850860970 🌍 Website: https://fudahospital.in/
02/02/2026
Never lose hope. Give yourself a chance by staying strong and fighting on. 💙
This National Cancer Prevention Month, Fuda Cancer Hospital Mumbai stands with every fighter, survivor, and family — spreading awareness, encouraging early detection, and offering compassionate care every step of the way.
Three Diagnoses, One Deep Bow: A Henan Family Finds Hope at Fuda
“I must bow to the hospital president and the department director—you saved our whole family.”
As she presented a banner of gratitude to President Niu Lizhi and Director Li Hongmei, Uncle Ding’s wife bowed deeply. Her eyes brimmed with tears, her voice trembling as she repeated again and again, “Thank you—truly, thank you…”
The story goes back to July 2025. Uncle Ding, in his seventies and from Henan Province, initially had only a cough with phlegm. Assuming it was chronic pharyngitis or a minor cold, he received injections and medication at a community clinic. But the symptoms lingered. A chest CT at a local hospital brought grave news from the doctor: “There’s a problem in the lungs.”
After visits to multiple hospitals, the diagnosis became clear: multiple nodules in both lungs. In the left upper lobe, there was a 2.1 × 1.7 cm solid nodule with irregular margins, suspicious for malignancy. The right lung harbored several ground-glass nodules, considered early-stage lung cancer; the largest measured 2.6 × 2.1 × 2.4 cm, located subpleurally in the posterior segment of the right upper lobe.
With a thick stack of reports, the family traveled to Beijing. Days of queuing and waiting led to a sobering assessment from specialists: heart disease, spinal problems, two prior stent procedures, advanced age, and lesions in both lungs. Surgery would be extremely risky—if one side were resected, the other might not be operable later, and postoperative recovery was uncertain. Each sentence felt like a hammer blow. Hope seemed to fade.
“Why not try Guangzhou Fuda Cancer Hospital?” A call from a sister-in-law pierced the darkness with a beam of light. In 2022, Uncle Ding’s niece had been diagnosed with advanced breast cancer and was told she had only three months to live. She endured rounds of chemotherapy and drug resistance as the disease progressed. When she arrived at Fuda in late 2024, a chest lesion had ulcerated to the size of an apple, causing relentless pain. After six interventional treatments combined with ADC therapy, the ulcer shrank to the size of a fingernail. “I used to think there were only surgery, chemo, and radiotherapy,” she said. “I didn’t know there were other paths until I came to Fuda.” An elder from the same village who had also had breast cancer spoke highly of Fuda as well.
Holding onto this belief, in August 2025 Uncle Ding’s family came to Medical Department Six at Fuda. Director Li Hongmei and her team conducted a thorough evaluation: bilateral emphysema, multiple lung nodules, cardiac stents requiring long-term medication. Conventional surgery carried extremely high risk and could severely impair lung function. After repeated discussions, the team chose a safer strategy—biopsy with simultaneous cryoablation of the high-risk left lung nodule first, followed by treatment of the multiple ground-glass nodules in the right lung.
Because Uncle Ding could not stop his cardiac medications for long, Director Li personally coordinated an expedited procedure. The surgery went smoothly. Postoperative pathology confirmed poorly differentiated adenocarcinoma of the left upper lobe. Uncle Ding recalled, “I went into the OR around 3 p.m. and came out by about 4. The puncture pain was minimal and tolerable.” What reassured the family most was his rapid recovery—he was soon able to get out of bed, with little impact on daily life. Back home, relatives and friends were amazed: “He doesn’t look like a patient at all—his energy is better than many healthy people!” Before this, they weren’t even sure he’d be able to walk back.
Two months later, Uncle Ding underwent another cryoablation, treating three nodules in the right lung in a single session. Recovery was again swift, life quickly returning to normal. He then completed several additional interventional treatments. “The doctors said this helps eliminate any hidden cancer cells that can’t be seen with the naked eye—making it safer,” he explained. Today, Uncle Ding continues regular treatment, speaking with vigor. He carefully records each session in a notebook and keeps the team’s attentiveness and warmth close to his heart.
Once, cancer felt like a verdict of despair for the entire family. Here, they found hope again.
“Patients keep recommending this hospital by word of mouth—it really is different,” Uncle Ding reflected. “If it can be treated, the doctors will do everything possible. If it can’t, they’ll tell you honestly and never delay.” Recently, his sister-in-law was diagnosed with colon cancer and also chose Medical Department Six. “At Fuda, I feel at ease,” she said.
When they presented the banner this time, Uncle Ding’s wife said with reddened eyes that she had taken photos with President Niu three times—each capturing a different emotion: from anxiety to trust, from gratitude to hope. A photograph records a journey; a banner carries a family’s heartfelt thanks.
Life’s path can sometimes feel like night falling as you walk. But there are people—and places—willing to light a lamp, to walk with you through wind and rain until dawn. For Uncle Ding’s family, Fuda is that light—illuminating not only the hospital room, but hearts that had nearly given up. And that light continues to warm many others who, like them, long for a new beginning.
Be the first to know and let us send you an email when Fuda Cancer Hospital - India posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Fuda is committed to providing cancer patients around the world with the best medical care.
Fuda Cancer Hospital is considered one of the BEST cancer hospitals in China by patients and is affiliated to Jinan University and Translational Medicine Center of Guangzhou Institute of Biomedicine and Health of Chinese Academy of Sciences. As a tertiary hospital, Fuda operates with international standards and was selected as the National Key Clinical Specialty (Oncology) in 2010. In 2014, Fuda was accredited by the Joint Commission International (JCI), a golden standard of medical service worldwide. Fuda is equipped with 400 beds, 45 VIP rooms and 500 medical staffs to help our patients.
Cancer treatment varies from patient to patient. Multiple Disciplinary Teams work in Fuda to personalize treatment for every single patient. Those teams include NanoKnife Ablation team (Irreversible Electroporation), Cryosurgical ablation team, cancer micro-vascular intervention team, combined immunotherapy team, and surgical team. Our clinical achievement and academic research are widely accepted by peer doctors and scientific journals. In Fuda, Doctors use more than 20 types of cancer treatment, including those mentioned above, to help our patient LIVE WITH CANCER as long as possible with a quality life.
Fuda highly focuses on research and application of advanced clinical procedures and pays tremendous attention on patient care. In the past two decades, Fuda has been active in promoting Minimally Invasive Treatments such as Cryosurgery, NanoKnife, micro-vascular intervention treatment and Brachytherapy. Fuda was the first in China to introduce NanoKnife for clinical use and has accumulated substantial clinical experience. Patients are not just receiving treatment in Fuda, they live a life in Fuda with their family.
To date, patients from over 110 countries were treated in Fuda and 50% of them are from South-East Asia, the Middle East, Oceania, Europe and North America. The number of patients treated in Fuda with Minimally Invasive treatments outnumbers any other hospital in the world. Fuda has received various awards in China and abroad for outstanding achievements in treating cancers and has been highly praised by patients worldwide.